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GUEST EDITORIAL

Infectious Complications in Patients With
Chronic Kidney Disease

T

he National Kidney Foundation’s clinical
practice guidelines for chronic kidney disease (CKD) include a classification system
characterizing the stages of CKD. Since the
development of this classification system, a
shift in focus has begun. Previously, attention
to CKD focused on patients in its final stage,
end-stage renal disease (ESRD), as shown by
the 1972 extension of the Medicare program to
include individuals with ESRD. Now, however, the potential size of the population in
earlier stages of CKD is becoming more recognized, as is the burden imposed by CKD
and its complications. For example, for many
years, clinical research centered on cardiovascular disease in dialysis patients (and, more
recently, in transplant patients).
Now, it appears that this and other complications are the major causes of morbidity and
mortality for CKD patients before they ever
reach ESRD. Although infectious complications have been a well-recognized complication in ESRD, this major source of morbidity
now appears present in earlier stages of CKD.
Some investigators have indicated there may
be a link between infectious events (ie, a link
between the increase in inflammatory mediators that occurs with these events and subsequent cardiovascular events, including myocardial infarction and congestive heart
failure). Infectious complications may occupy
a far more important place in the chain of
morbidity and mortality than previously appreciated, which suggests that prevention and
intervention approaches should be considered
more actively.
This issue of Advances in Chronic Kidney Disease covers many topics in the area of infectious
complications in CKD patients. Included are
articles discussing surveillance data on hospitalization for infection in dialysis, CKD, and nonCKD patients; rates of vaccination to prevent
infections such as pneumonia; the diagnosis and
management of catheter-related bacteremia;
biofilm (its generation and consequences); the
use of antibiotics instilled into dialysis catheters
(so-called antibiotic locks); important considerations in antibiotic therapy for common infec-

tions in dialysis patients; the diagnosis and
management of enteric peritonitis in peritoneal
dialysis patients; and infections after kidney
transplantation. The articles provide reviews
and make observations on clinical practice (prevention and treatment) and public health.
Infectious complications are 3 to 5 times
more common in CKD than in non-CKD patients and up to 8 times more common in
dialysis patients. Interestingly, the pneumonia
rate in the CKD population appears to be
almost 80% of the rate in the dialysis population. From this perspective, major infections
such as pneumonia, sepsis, and urinary tract
infection can be seen as major sources of morbidity, which is consistent with the reduced
immunological function reported for patients
with kidney disease. Furthermore, as noted by
Dr Foley, infectious events may not be the
isolated phenomena they were once thought
to be. After a major infectious episode, cardiovascular disease event rates are markedly increased, suggesting that infection may play a
synergistic role in the inflammatory hypothesis of vascular disease, which is prominent in
CKD patients. Efforts to prevent major infectious complications are inadequate. Influenza
vaccinations have reached only 58% of patients; the target is 90%. The rate for pneumococcal pneumonia vaccination is comparably
low. The rate for hepatitis vaccination has not
reached its target either and remains a major
source of concern. Sepsis and urinary tract
infection in the CKD, ESRD, and transplant
populations need attention. Hepatitis C is not
addressed, but it too must be remembered; in
many areas of the world, it is a major complication in ESRD patients.
Many sepsis complications result from the
use of dialysis catheters. This is a major problem in the United States. The 3 articles on
biofilm, dialysis catheter complications, and
antibiotic locks address different aspects of
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the dialysis catheter problem, each article ending with a recommendation that use of these
devices be avoided, if possible. The use of
antibiotics in ESRD patients and the potential
development of antibiotic-resistant strains is a
very important matter for discussion and is
best addressed at the local level. It is critically
important to monitor the antibiograms of isolates from local dialysis units because the resistance pattern observed may differ from that
observed for hospital- or community-acquired
infections.
Gram-negative peritonitis in patients receiving peritoneal dialysis is an important
clinical problem. These infections appear to be
associated with abdominal visceral microperforations or transmural migration of bacteria,
leading to serious and potentially life-threatening complications. Prolonged use of antibiotic may predispose patients to secondary
fungal infections that require removal of the
peritoneal dialysis catheter. This article leads
the reader through the diagnostic and therapeutic issues in this problem. Finally, infectious complications in the posttransplantation
period are reviewed. Urinary tract infections

continue to be a formidable challenge in
adults and even more so in children; viral
infections and other emerging infections are
touched on as well. Prophylaxis of urinary
tract infection may need to be reconsidered,
given the high rates of infection in the first 3
years after transplantation. Issues in transplantation-related infection also should be
viewed in light of the multiplier potential
represented by infection; after transplant failure, the second-leading cause of a lost kidney
is death from cardiovascular disease. Prevention measures still lag behind in transplantation patients. This is especially true regarding
the rates of influenza and pneumococcal
pneumonia vaccination. Such clinical care
should be routine in the long-term follow-up
of these patients. In short, infectious complications need more attention, including preventive measures in addition to early diagnosis and treatment.
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